Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1975 1
1977 1
1978 2
1984 1
1986 1
1990 1
1991 1
1993 6
1994 7
1995 3
1996 3
1997 3
1998 1
1999 1
2000 1
2001 2
2002 6
2003 2
2004 4
2005 1
2006 1
2007 1
2008 1
2010 1
2016 1
2017 5
2018 2
2019 2
2020 2
2021 4
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study.
Murrell DF, Caux F, Patsatsi A, Hagino O, Rudnicka L, Vassileva S, Uzun S, Ye J, Yen K, Arora P, Gourlay SG, Joly P, Werth VP. Murrell DF, et al. Among authors: gourlay sg. J Invest Dermatol. 2024 Mar 16:S0022-202X(24)00192-1. doi: 10.1016/j.jid.2024.02.023. Online ahead of print. J Invest Dermatol. 2024. PMID: 38493933 Free article.
Adaptive Manufacturing for Healthcare During the COVID-19 Emergency and Beyond.
Vallatos A, Maguire JM, Pilavakis N, Cerniauskas G, Sturtivant A, Speakman AJ, Gourlay S, Inglis S, McCall G, Davie A, Boyd M, Tavares AAS, Doherty C, Roberts S, Aitken P, Mason M, Cummings S, Mullen A, Paterson G, Proudfoot M, Brady S, Kesterton S, Queen F, Fletcher S, Sherlock A, Dunn KE. Vallatos A, et al. Among authors: gourlay s. Front Med Technol. 2021 Aug 2;3:702526. doi: 10.3389/fmedt.2021.702526. eCollection 2021. Front Med Technol. 2021. PMID: 35047941 Free PMC article.
Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study.
Murrell DF, Patsatsi A, Stavropoulos P, Baum S, Zeeli T, Kern JS, Roussaki-Schulze AV, Sinclair R, Bassukas ID, Thomas D, Neale A, Arora P, Caux F, Werth VP, Gourlay SG, Joly P; BELIEVE trial investigators. Murrell DF, et al. Among authors: gourlay sg. Br J Dermatol. 2021 Oct;185(4):745-755. doi: 10.1111/bjd.20431. Epub 2021 Jun 15. Br J Dermatol. 2021. PMID: 33942286 Free PMC article. Clinical Trial.
72 results